The Swiss pharma has inked several collaborations in this field, suggesting it sees the approach as promising to rid the body ...

Roche has parted with $1.4 billion upfront to secure rights to an obesity candidate developed by Zealand Pharma, taking its tally of weight-loss candidates in clinical development to five.

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

The rain started as we entered the vast cemetery in Avignon. We were seeking France’s greatest unsung war hero or, rather, his final resting place We had brought no umbrella to the search. Of ...

If you have never heard of Simon Roche, and you very possibly haven’t, he is the official spokesman for the Suidlanders. The group, led by the reclusive Gustav Muller, is headquartered in the small ...

This unique world exists on board the ship Logos Hope, my home for the next 2 years. I have been living on board for over a month and the life on Logos Hope is both exciting and challenging at the ...